Your email has been successfully added to our mailing list.

×
-0.0100425681695687 -0.0177422370838054 -0.0100425681695687 -0.0133424262756701 0.0339555399117839 0.143950810115165 0.182449154686349 0.305643857314136
Stock impact report

Cipher Pharmaceuticals' PLECANATIDE accepted for review by Health Canada [Seeking Alpha]

SYNERGY PHARMACEUTICALS (SGYP) 
Last synergy pharmaceuticals earnings: 11/8 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.synergypharma.com
Company Research Source: Seeking Alpha
Cipher Pharmaceuticals' PLECANATIDE accepted for review by Health CanadaCipher Pharmaceuticals (OTC:CPHRF)announces that its New Drug Submission ("NDS") for plecanatide for irritable bowel syndrome with constipation ("IBS-C") has been accepted by Health Canada.Cipher acquired the Canadian rights to develop, market, distribute and sell plecanatide (branded as TRULANCE in U.S.) from Synergy Pharmaceuticals in February 2018.Click to subscribe to real-time analytics on CPHRFNow read:Bovie Medical appoints Tara H. Semb as CFO »Subscribefor full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
SGYP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SGYP alerts
Opt-in for
SGYP alerts

from News Quantified
Opt-in for
SGYP alerts

from News Quantified